<DOC>
	<DOCNO>NCT01515722</DOCNO>
	<brief_summary>Study Objectives : To explore effectiveness adjunctive intervention enhance medication compliance persistence patient Overactive Bladder ( OAB ) , thereby improve treatment outcome Study Hypothesis : Health Education Intervention ( HEI ) enhance medication compliance persistence , thereby improve treatment outcome conjunction pharmacological therapy OAB patient Study Design : 6-month , randomize , open-label , multi-center trial 13 university hospital</brief_summary>
	<brief_title>Interventions Enhance Medication Persistence Compliance Patients With Overactive Bladder</brief_title>
	<detailed_description>Treatment - Fesoterodine ( Toviaz ) 4 8mg Interventions ( 2 arm ) - Arm 1 : No intervention Patients arm give HEI conjunction pharmacotherapy ( Toviaz ) develop trial . - Arm 2 : Health education intervention ( HEI ) HEI perform trained study coordinator leaflet design trial compose 4 part . 1 . Part 1 : Understanding OAB Physiology bladder Definition , symptom prevalence OAB OAB treatable condition . There many option may help symptom . Lifestyle change Medications Bladder train Pelvic floor muscle exercise 2 . Part 2 : Behavioral/lifestyle modification Modification dietary habit Limit bladder irritants- caffeine ( coffee , tea , coke ... ) , juice , chemical flavor , spicy food . etc . Altering fluid intake Weight management Learn weight affect condition Stop smoking Constipation management 3 . Part 3 : Bladder training Timed voiding- Goal urinating every 3 4 hour day without fear wet accident . Urgency suppression Pelvic muscle contraction , count backwards 100 7seconds , etc Pelvic floor muscle exercise Contraction ( fast slow ) relax muscle count 3 . Repeat fast slow contraction 10 - 15 time . Do least 3 time day . 4 . Part 4 : Understanding antimuscarinics How medicine work How take Tips may help manage side effects- dry mouth , constipation Therapy expectation 5 . HEI include 3-day void diary self track method .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<criteria>Female age ≥ 18 year OAB symptoms ≥ 3 month The sum score OABSS ≥ 3 score question no.3 ( urgency ) ≥ 2 The sum score OAB V8 ≥ 8 Any condition would contraindication anticholinergic treatment Symptomatic acute UTI runin period Diagnosed suspected interstitial cystitis Treatment anticholinergic drug within 12 month prior Screening persist 3 month Treatment within 14 day precede Screening , expect initiate treatment study treatment overactive bladder . An indwelling catheter practice intermittent selfcatheterization Pregnant nursing woman</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Medication Persistence</keyword>
	<keyword>Compliance</keyword>
	<keyword>Health Education Intervention ( HEI )</keyword>
</DOC>